相关实验视频
Updated: May 15, 2025

13:04
Overexpressing Long Noncoding RNAs Using Gene-activating CRISPR
Published on: March 1, 2019
8.8K
lncRNA EGOT 是HPV感染的标记物,也是HNSCC患者的预后因素
Tomasz Kolenda1,2,3,4, Piotr Białas5, Kacper Guglas1,2
1Research and Implementation Unit, Greater Poland Cancer Centre, Garbary 15, 61-866 Poznan, Poland.
Biomedicines
|April 29, 2025
概括
这项研究确定了EGOT基因作为头部和部状细胞癌 (HNSCC) 的潜在生物标志物. 过度表达的EGOT在HPV阳性HNSCC中表明更好的生存率和帮助患者分层.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 高风险的人类乳头瘤病毒 (HPV) 基蛋白E6和E7通过破坏宿主细胞功能驱动口腔癌.
- 表观基因组的改变,特别是涉及长非编码RNA (lncRNAs),是HPV相关的致癌的关键.
研究的目的:
- 分析与HPV相关的头支状细胞癌 (HNSCC) 中的lncRNA表达.
- 确定临床验证的生物标志物用于HNSCC的早期查和治疗干预.
- 确定HPV阳性HNSCC. lncRNAs在HPV阳性的生物和临床意义.
主要方法:
- 在与HPV相关的HNSCC样本中分析lncRNA表达水平.
- lncRNA表达与临床参数和患者存活率的相关性.
主要成果:
- 在HPV阳性HNSCC样本中观察到EGOT基因的显著过度表达.
- EGOT表达可以区分HPV阴性和HPV阳性HNSCC病例.
- 高EGOT表达与改善的整体存活率 (OS) 相相关,并表明潜在的治疗耐药性,作为预后因素.
结论:
- 在HNSCC中,EGOT表达分析对临床应用具有前景.
- EGOT可以改善患者分层和HNSCC的治疗策略.
- 对EGOT作用的进一步研究可能会导致用于早期检测和向治疗的新生物标志物.
相关概念视频
lncRNA - Long Non-coding RNAs
8.4K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.4K
Types of RNA
5.5K
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
RNA Performs Diverse...
5.5K
Transducer Mechanism: Nuclear Receptors
1.2K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.2K
Non-LTR Retrotransposons
11.3K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.3K
Ribosomal RNA Synthesis
13.0K
Ribosome synthesis is a highly complex and coordinated process involving more than 200 assembly factors. The synthesis and processing of ribosomal components occurs not only in the nucleolus but also in the nucleoplasm and the cytoplasm of eukaryotic cells.
Ribosome biogenesis begins with the synthesis of 5S and 45S pre-rRNAs by distinct RNA polymerases. The primary transcripts are extensively processed and modified before they are bound and folded by ribosomal proteins and assembly factors,...
Ribosome biogenesis begins with the synthesis of 5S and 45S pre-rRNAs by distinct RNA polymerases. The primary transcripts are extensively processed and modified before they are bound and folded by ribosomal proteins and assembly factors,...
13.0K
RNA Interference
25.8K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
25.8K

